drugset / Trial / NCT00475527

Helicobacter Pylori and Iron Deficiency: Prevalence of Association and Effect of Therapy

NCT00475527 ↗

Phase 4 Withdrawn Hadassah Medical Organization
RandomizedParallel-groupOpen-labelTreatment

Summary

Iron deficiency anemia (IDA) is a major health problem in children, effecting up to 20% of young children. Helicobacter pylori (HP) infection is also reported to be prevalent in children. Several large epidemiologic studies support an association between HP infection and lower iron stores. Other small studies suggest improvement in anemia following HP treatment. We assume that the prevalence of HP infection in Israeli children diagnosed with IDA is high and that that adding therapy for HP in those children will improve the response to iron deficiency.

Timeline

Start
—
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped (Enrollment): “problem of accrual”

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified — —
Subject Clarithromycin Small molecule — —
Subject Metronidazole Small molecule — —
Subject Omeprazole Other / unclassified — —